A reduced expression of CD21 on circulating B cells is consistent with observations in several other autoimmune disorders and chronic inflammatory conditions, where an enrichment of CD21−/low B cells has been reported (reviewed by Gjertsson et al. [49]). The gene discussed is CR2; the disease is autoimmune disease.